Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells

Molecular Endocrinology

Volumn 15, Issue 7, 2001, Pages 1154-1169

  Benoit, G R ^a   Flexor, M ^a   Besancon F ^b   Altucci, L ^c,d   Rossin, A ^c   Hillion, J ^a   Balajthy, Z ^a   Legres, L ^a   Segal Bendirdjian, E ^a   Gronemeyer, H ^c   Lanotte, M ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT CURIE   (France)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; HYBRID PROTEIN; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL; PRIORITY JOURNAL; PROMYELOCYTE; SERUM FACTOR; SIGNAL TRANSDUCTION;

EID: 17844406380     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.15.7.0654     Document Type: Article

References (57)

1. Retinoids in cancer chemoprevention
2. Advances in the development of retinoids as chemopreventive agents
3. 13-cis-retinoic acid and interferon α-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin
4. Topical treatment of epidemic Kaposi's sarcoma with all-trans-retinoic acid
5. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck
6. A decade of molecular biology of retinoic acid receptors
7. Transcription factors 3: Nuclear receptors
8. The nuclear receptor superfamily: The second decade
9. Retinoids selective for retinoid X receptor response pathways
10. Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor
11. Two distinct actions of retinoid-receptor ligands
12. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells
13. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers
14. The phantom ligand effect: Allosteric control of transcription by the retinoid X receptor
15. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation
16. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)
17. Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line
18. A mutated PML/RARA found in the retinoid maturation resistant NB4 subclone, NB4-R2, blocks RARA and wild-type PML/RARA transcriptional activities
19. The PML-RAR α fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
20. Role of PML in cell growth and the retinoic acid pathway
21. Nuclear bodies: Multifaceted subdomains of the interchromatin space
22. The PML nuclear bodies: Actors or extras?
23. Acute promyelocytic leukemia: From genetics to treatment
24. Deconstructing a disease: RARα, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia
25. Retinoid receptors in health and disease: Co-regulators and the chromatin connection
26. Mechanisms of apoptotic cell death
27. Cell death in development
28. Serine/threonine phosphorylation in cytokine signal transduction
29. Apoptosis: The germs of death
30. PML induces a novel caspase-independent death process
31. PML is essential for multiple apoptotic pathways
32. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis
33. The acute promyelocytic leukemia-specific PML-RAR α fusion protein inhibits differentiation and promotes survival of myeloid precursor cells
34. PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells
35. Targeting the PML/RAR α translocation product triggers apoptosis in promyelocytic leukemia cells
36. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid
37. Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis retinoic acid induces apoptosis independent of maturation and Bcl-2 expression
38. Induction of apoptosis without differentiation by retinoic acid in PLB-985 cells requires the activation of both RAR and RXR
39. Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity
40. Dual mechanism of action of the retinoid CD437: Nuclear retinoic acid receptor-mediated suppression of squamous differentiation and receptor-independent induction of apoptosis in UMSCC22B human head and neck squamous cell carcinoma cells
41. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3
42. Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl β-glucuronide
43. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators
44. Polarity-specific activities of retinoic acid receptors determined by a co-repressor
45. Coexpression of nuclear receptor partners increases their solubility and biological activities
46. Pure and functionally homogeneous recombinant retinoid X receptor
47. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR α)-, RAR β-, or RAR γ-selective ligand in combination with a retinoid X receptor-specific ligand
48. RXRα-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids
49. The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development
50. Specific and redundant functions of retinoid X Receptor/Retinoic acid receptor heterodimers in differentiation, proliferation, and apoptosis of F9 embryonal carcinoma cells
51. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines
52. Retinoid-X receptor signalling in the developing spinal cord
53. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain
54. A simple salting out procedure for extracting DNA from human nucleated cells
55. Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process
56. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation